Topical medications jump 9.8% in unmanaged comp claims in 2017
Reprints
The prescribing of topical pain-management creams rose in 2017 workers compensation claims that were not monitored by pharmacy benefits managers, according to a report released Wednesday by Coventry Workers Comp.
The second in a series covering workers comp drugs trends, Downers Grove, Illinois-based Coventry compared its 2017 data on managed claims, representing 77.6% of total comp prescriptions, and unmanaged claims, representing 24.7%, to draw attention to concerns, according to the report.
Researchers found that overall drug utilization in comp was down in 2017 — especially in opioids and compounds medication, an overall industry trend — with 5.9% drops in managed claims and 7.4% in unmanaged claims.
But topical medications prescribed in the unmanaged category of claims jumped 9.8%, compared with a 6.5% drop in the managed category. This was driven by “high-dollar, private-label topical analgesics marketed directly to physicians’ offices… contributing to the significant rise in unmanaged topical utilization per claim — demonstrating the need for continued focus on moving these transactions into the (pharmacy benefits manager),” the report stated.
Read Next
-
Opioids remain most prescribed pain medication in California
As the overuse and costs of prescription pain medications in the U.S. continues, California's workers compensation system reported opioids were still the state's No. 1 prescribed drug.
Related Stories
-
Opioids remain most prescribed pain medication in California
-
Insurance trades weigh in on compound medication preauthorization proposal
-
Class action suit alleging wasteful eye medication packaging reinstated
